EP
ARRY

Eversept Partners’s Array Biopharma Inc ARRY Stock Holding History

Eversept Partners’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-214,112
Closed -$5.22M – 73
2019
Q1 		$5.22M Buy
214,112
+123,700
+137% +$2.58M 1.52% 19
2018
Q4 		$1.29M Buy
90,412
+30,000
+50% +$455K 0.7% 31
2018
Q3 		$918K Buy
60,412
+12,000
+25% +$184K 0.4% 39
2018
Q2 		$812K Sell
48,412
-309,315
-86% -$4.92M 0.37% 47
2018
Q1 		$5.84M Sell
357,727
-880,076
-71% -$14.1M 2.71% 14
2017
Q4 		$15.8M Buy
+1,237,803
New +$14.1M 9.12% 2

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Eversept Partners's ARRY Position: Q2 2019 in Review

Eversept Partners sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 214,112 shares — an estimated $5.22M sold.

Eversept Partners first reported a position in ARRY in Q4 2017 and held it in 6 quarters. The position peaked at $15.8M in Q4 2017. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Eversept Partners reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Eversept Partners sold 214,112 Array Biopharma Inc shares in Q2 2019, an estimated $5.22M.
  • Eversept Partners first reported a position in Array Biopharma Inc in Q4 2017 and held it in 6 quarters.
  • Eversept Partners's Array Biopharma Inc position peaked at $15.8M in Q4 2017.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Eversept Partners's 13F filing for Q2 2019, filed 13 Aug 2019.